The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cell Therapy Technologies Market Research Report 2025

Global Cell Therapy Technologies Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1888088

No of Pages : 84

Synopsis

The global Cell Therapy Technologies market was valued at US$ 9855.2 million in 2023 and is anticipated to reach US$ 17610 million by 2030, witnessing a CAGR of 8.2% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Cell Therapy Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Therapy Technologies.

Report Scope

The Cell Therapy Technologies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cell

Therapy Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cell Therapy Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.


By Company

  • Danaher
  • Thermo Fisher Scientific
  • Merck
  • Terumo
  • BD
  • Lonza Group
  • GE Healthcare
  • Sartorius
  • Stemcell Technologies
  • Miltenyi Biotec

Segment by Type

  • Equipment
  • Consumables
  • Others

Segment by Application

  • Human
  • Animal

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Therapy Technologies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Therapy Technologies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Equipment
1.2.3 Consumables
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cell Therapy Technologies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Human
1.3.3 Animal
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Therapy Technologies Market Perspective (2019-2030)
2.2 Cell Therapy Technologies Growth Trends by Region
2.2.1 Global Cell Therapy Technologies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cell Therapy Technologies Historic Market Size by Region (2019-2024)
2.2.3 Cell Therapy Technologies Forecasted Market Size by Region (2025-2030)
2.3 Cell Therapy Technologies Market Dynamics
2.3.1 Cell Therapy Technologies Industry Trends
2.3.2 Cell Therapy Technologies Market Drivers
2.3.3 Cell Therapy Technologies Market Challenges
2.3.4 Cell Therapy Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Therapy Technologies Players by Revenue
3.1.1 Global Top Cell Therapy Technologies Players by Revenue (2019-2024)
3.1.2 Global Cell Therapy Technologies Revenue Market Share by Players (2019-2024)
3.2 Global Cell Therapy Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Therapy Technologies Revenue
3.4 Global Cell Therapy Technologies Market Concentration Ratio
3.4.1 Global Cell Therapy Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy Technologies Revenue in 2023
3.5 Cell Therapy Technologies Key Players Head office and Area Served
3.6 Key Players Cell Therapy Technologies Product Solution and Service
3.7 Date of Enter into Cell Therapy Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Therapy Technologies Breakdown Data by Type
4.1 Global Cell Therapy Technologies Historic Market Size by Type (2019-2024)
4.2 Global Cell Therapy Technologies Forecasted Market Size by Type (2025-2030)
5 Cell Therapy Technologies Breakdown Data by Application
5.1 Global Cell Therapy Technologies Historic Market Size by Application (2019-2024)
5.2 Global Cell Therapy Technologies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cell Therapy Technologies Market Size (2019-2030)
6.2 North America Cell Therapy Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cell Therapy Technologies Market Size by Country (2019-2024)
6.4 North America Cell Therapy Technologies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Therapy Technologies Market Size (2019-2030)
7.2 Europe Cell Therapy Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cell Therapy Technologies Market Size by Country (2019-2024)
7.4 Europe Cell Therapy Technologies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Therapy Technologies Market Size (2019-2030)
8.2 Asia-Pacific Cell Therapy Technologies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cell Therapy Technologies Market Size by Region (2019-2024)
8.4 Asia-Pacific Cell Therapy Technologies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Therapy Technologies Market Size (2019-2030)
9.2 Latin America Cell Therapy Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cell Therapy Technologies Market Size by Country (2019-2024)
9.4 Latin America Cell Therapy Technologies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Therapy Technologies Market Size (2019-2030)
10.2 Middle East & Africa Cell Therapy Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cell Therapy Technologies Market Size by Country (2019-2024)
10.4 Middle East & Africa Cell Therapy Technologies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Danaher
11.1.1 Danaher Company Detail
11.1.2 Danaher Business Overview
11.1.3 Danaher Cell Therapy Technologies Introduction
11.1.4 Danaher Revenue in Cell Therapy Technologies Business (2019-2024)
11.1.5 Danaher Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Cell Therapy Technologies Introduction
11.2.4 Thermo Fisher Scientific Revenue in Cell Therapy Technologies Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Cell Therapy Technologies Introduction
11.3.4 Merck Revenue in Cell Therapy Technologies Business (2019-2024)
11.3.5 Merck Recent Development
11.4 Terumo
11.4.1 Terumo Company Detail
11.4.2 Terumo Business Overview
11.4.3 Terumo Cell Therapy Technologies Introduction
11.4.4 Terumo Revenue in Cell Therapy Technologies Business (2019-2024)
11.4.5 Terumo Recent Development
11.5 BD
11.5.1 BD Company Detail
11.5.2 BD Business Overview
11.5.3 BD Cell Therapy Technologies Introduction
11.5.4 BD Revenue in Cell Therapy Technologies Business (2019-2024)
11.5.5 BD Recent Development
11.6 Lonza Group
11.6.1 Lonza Group Company Detail
11.6.2 Lonza Group Business Overview
11.6.3 Lonza Group Cell Therapy Technologies Introduction
11.6.4 Lonza Group Revenue in Cell Therapy Technologies Business (2019-2024)
11.6.5 Lonza Group Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Detail
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Cell Therapy Technologies Introduction
11.7.4 GE Healthcare Revenue in Cell Therapy Technologies Business (2019-2024)
11.7.5 GE Healthcare Recent Development
11.8 Sartorius
11.8.1 Sartorius Company Detail
11.8.2 Sartorius Business Overview
11.8.3 Sartorius Cell Therapy Technologies Introduction
11.8.4 Sartorius Revenue in Cell Therapy Technologies Business (2019-2024)
11.8.5 Sartorius Recent Development
11.9 Stemcell Technologies
11.9.1 Stemcell Technologies Company Detail
11.9.2 Stemcell Technologies Business Overview
11.9.3 Stemcell Technologies Cell Therapy Technologies Introduction
11.9.4 Stemcell Technologies Revenue in Cell Therapy Technologies Business (2019-2024)
11.9.5 Stemcell Technologies Recent Development
11.10 Miltenyi Biotec
11.10.1 Miltenyi Biotec Company Detail
11.10.2 Miltenyi Biotec Business Overview
11.10.3 Miltenyi Biotec Cell Therapy Technologies Introduction
11.10.4 Miltenyi Biotec Revenue in Cell Therapy Technologies Business (2019-2024)
11.10.5 Miltenyi Biotec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’